Washington Homeopathic Products Quebracho 4C Fever Medicine Recall
Washington Homeopathic Products is recalling Quebracho 4C Fever homeopathic medicine (Lot #28930, expiration 8/17/2026) distributed nationwide due to out-of-specification test results from identification testing.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with an out-of-specification testing result for a homeopathic medicine. The source text does not report any illnesses, injuries, or specific safety hazard beyond the failed identification test, which qualifies as a quality/labeling defect rather than a direct safety threat.
Plain-English summary
Washington Homeopathic Products, Inc. is recalling Quebracho 4C, Fever*, 20% Alcohol homeopathic medicine, packaged in 100ml bottles. The product was distributed nationwide in the USA.
The recall is being issued because the product failed identification testing based on HPTLC analysis, with results obtained that fell out of specification. This means the product did not meet the required standards for identity verification during testing.
The affected lot is Lot #28930 with an expiration date of 8/17/2026. Consumers who have purchased this product should stop using it and may contact Washington Homeopathic Products, Inc. at 260 JR Hawvermale Way, Berkeley Springs, WV 25411 for further information.
The recalled product
- Product
- Quebracho 4C, Fever*, 20% Alcohol, Packaged as 100ml, WHP Homeopathic Medicine, Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV 25411.
- Manufacturer
- Washington Homeopathic Products, Inc.
- Category
- Drug — Homeopathic Medicine
- Hazard
- identification-test-failure
- out-of-specification
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 28930
- Exp 8/17/2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27